Selected discussion
Repeated fecal microbiota transplantation in dogs with chronic enteropathy can decrease disease activity and corticosteroid usage.
Clinical evidence update from Journal of the American Veterinary Medical Association
Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated A study published in Journal of the American Veterinary Medical Association in 2026 evaluated repeated fecal microbiota transplantation in dogs with chronic enteropathy can decrease disease activity and corticosteroid usage..
Key Findings Evaluate clinical and fecal parameters in dogs with refractory chronic enteropathy (CE) treated with repeated fecal microbiota transplantation (FMT) as adjunct treatment. This was a prospective longitudinal observational study from September 25, 2021, to June 20, 2024. Thirty-nine dogs received 2 to 3 rectal FMTs over 1 month. Canine inflammatory bowel disease activity index (CIBDAI) and fecal samples were…
Discussion thread
Community replies
Follow the line down to read the conversation in order.
No replies yet
No replies yet. Be the first professional to join this discussion.
Use the reply box above to start the conversation.


Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.